Type 2 & other diabetes

Acceptability and psychometric properties of four scales assessing the impact of Type 2 diabetes on quality of life—Results of ‘YourSAY: Quality of Life’

Diabet MedPublished Cross-sectional study

Authors' conclusion

The current study provides novel insights into the acceptability, validity and reliability of diabetes-specific QoL measures for adults with T2D. Consistent with the published Type 1 diabetes cohort findings, the DIDP is recommended as a brief, acceptable and psychometrically sound measure. However, selection needs to be considered in the context of the specific research or clinical aims and further evidence (e.g. responsiveness) may be required before it can be recommended for use in trials or prospective studies.

Study context

Population
Adults (≥18 years) with T2D living in the UK or AustraliaUK n = 1465 · or Australia 248
Exposure
Four diabetes-specific Quality of Life (QoL) scales: ADDQoL vs DCP vs DIDP vs Diabetes QoL-Q
Outcome
Psychometric properties and acceptability of four diabetes-specific QoL scales
Methodological detailsonline survey, scales presented in randomised order, analysed by country for cross-country reproducibility
  • Online survey
  • Scales presented in randomised order
  • Analysed by country for cross-country reproducibility

Main finding

As reported in the abstract

GroupValueCompletion ratePositive user ratings
DIDP97%97%≥84%

DIDP

Value97%
Completion rate97%
Positive user ratings≥84%
Completion rates across scales
≥89%

Observational data: associations, not effects.

Further findings

Scale-level floor effects may suggest domain omissions for the brief DIDP

Original publication

Acceptability and psychometric properties of four scales assessing the impact of Type 2 diabetes on quality of life—Results of ‘YourSAY: Quality of Life’. Diabet Med. Published 30 October 2024. doi:10.1111/dme.15461

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.